We are proud of the transformative impact IBRANCE has had on the treatment of HR+, HER2- metastatic breast cancer... Oct 09
The combination of two LAABs is also designed to reduce the risk of resistance developed by the SARS-CoV-2 virus.... Oct 09
-Advertisements-